While presenting the bill to the House Health & Welfare Committee last week, Nichols said their anti-mRNA stance stems from the fact that the COVID-19 vaccines were initially allowed under emergency use authorizations (EUAs) from the Food and Drug Administration, not the agency’s full regulatory approval. “We have issues that this was fast-tracked,” she told fellow lawmakers, according to reporting from local news outlet KXLY.com. […] “They ultimately were approved under the ordinary approval process and did ultimately, you know, survive the scrutiny of being subjected to all the normal tests,” Rep. Ilana Rubel, a democrat from Boise, said. Nichols seemed unswayed by the point, however, with KTVB7 reporting that she responded that the FDA’s approval “may not have been done like we thought it should’ve been done.”
To date, more than 269 million people in the US have received at least one COVID-19 vaccine, and over 700 million doses of mRNA-based vaccines have gone into American arms, according to data from the Centers for Disease Control and Prevention. The agency keeps close tabs on safety through various national surveillance systems. Although the shots do carry some risk (as is the case for any medical intervention), they have proven remarkably safe amid widespread use of hundreds of millions of doses in the US and worldwide. A study released late last year found that COVID-19 vaccination in the US alone averted more than 18 million additional hospitalizations and more than 3 million additional deaths from the pandemic coronavirus, SARS-CoV-2. The National Human Genome Research Institute notes that mRNA “is a type of single-stranded RNA involved in protein synthesis. mRNA is made from a DNA template during the process of transcription. The role of mRNA is to carry protein information from the DNA in a cell’s nucleus to the cell’s cytoplasm (watery interior), where the protein-making machinery reads the mRNA sequence and translates each three-base codon into its corresponding amino acid in a growing protein chain.”
mRNA-based vaccines made their public debut amid the COVID-19 pandemic, but researchers have been “working toward these vaccines for decades beforehand,” adds Ars.
Read more of this story at Slashdot.